Prio Wealth Limited Partnership’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $44.5K | Hold |
941
| – | – | ﹤0.01% | 264 |
|
2024
Q2 | $47.3K | Hold |
941
| – | – | ﹤0.01% | 257 |
|
2024
Q1 | $105K | Hold |
941
| – | – | ﹤0.01% | 266 |
|
2023
Q4 | $54.6K | Hold |
941
| – | – | ﹤0.01% | 255 |
|
2023
Q3 | $29.9K | Hold |
941
| – | – | ﹤0.01% | 247 |
|
2023
Q2 | $77.4K | Hold |
941
| – | – | ﹤0.01% | 251 |
|
2023
Q1 | $96.7K | Hold |
941
| – | – | ﹤0.01% | 245 |
|
2022
Q4 | $138K | Hold |
941
| – | – | 0.01% | 246 |
|
2022
Q3 | $159K | Hold |
941
| – | – | 0.01% | 243 |
|
2022
Q2 | $109K | Hold |
941
| – | – | ﹤0.01% | 250 |
|
2022
Q1 | $94K | Hold |
941
| – | – | ﹤0.01% | 262 |
|
2021
Q4 | $146K | Hold |
941
| – | – | ﹤0.01% | 270 |
|
2021
Q3 | $222K | Hold |
941
| – | – | 0.01% | 260 |
|
2021
Q2 | $320K | Hold |
941
| – | – | 0.01% | 231 |
|
2021
Q1 | $381K | Hold |
941
| – | – | 0.01% | 216 |
|
2020
Q4 | $626K | Hold |
941
| – | – | 0.02% | 165 |
|
2020
Q3 | $438K | Hold |
941
| – | – | 0.02% | 177 |
|
2020
Q2 | $551K | Hold |
941
| – | – | 0.03% | 164 |
|
2020
Q1 | $137K | Hold |
941
| – | – | 0.01% | 229 |
|
2019
Q4 | $135K | Hold |
941
| – | – | 0.01% | 256 |
|
2019
Q3 | $37K | Hold |
941
| – | – | ﹤0.01% | 256 |
|
2019
Q2 | $95K | Hold |
941
| – | – | ﹤0.01% | 242 |
|
2019
Q1 | $123K | Hold |
941
| – | – | 0.01% | 237 |
|
2018
Q4 | $95K | Hold |
941
| – | – | 0.01% | 219 |
|
2018
Q3 | $235K | Hold |
941
| – | – | 0.01% | 223 |
|
2018
Q2 | $420K | Hold |
941
| – | – | 0.02% | 178 |
|
2018
Q1 | $371K | Buy |
+941
| New | +$371K | 0.02% | 183 |
|